Industry News – Health Canada approves laser therapy devices
Maria DiDanieliFeatures Clinical Techniques
July 13, Solon, OH – Multi Radiance Medical, an
international laser therapy company, is pleased to announce that Health Canada
has approved the MR4 laser therapy devices for use in Canada.
This approval through the Therapeutic Products Directorate
of the Medical Devices Bureau of Health Canada includes console and
portable units, emitters and the MR4 LaserStim flagship device which is the
world’s most advanced pain relief modality.
The MR4 LaserStim is the only hybrid technology that
combines a laser and electrical neuro-stimulation. In addition, the MR4
LaserStim comes with exclusive TARGET technology (Treatment Area Recognition
and Guidance Enhanced Technology), which identifies optimal treatment areas. As
the handheld LaserStim emitter is moved over the tissue, treatment areas are
identified assisting the clinician with the correct dose of highly targeted
The effectiveness of laser therapy is backed by over 4000
clinical studies. The MR4 laser uses
25,000 – 50,000mW of super pulsed power which is greater than most class IV
lasers with a higher degree of safety.
This provides accelerated pain relief and healing.
Max Kanarsky, President of Multi Radiance Medical states,
"Over 400,000 Multi Radiance Medical devices have been sold in more than
30 countries providing relief via 300+ treatment protocols. We are excited to now be able to offer MR4
laser therapy devices to clinicians throughout Canada.”
MR4 lasers are utilized for athletes around the world
including players on NHL teams and many NBA and MLB teams.
For additional information please
contact Susan Vetrone at email@example.com
Print this page